Bioregenx (BRGX) Current Deferred Revenue (2022 - 2026)
Bioregenx (BRGX) posted Current Deferred Revenue of $56528.0 for Q1 2026, down 6.14% on a QoQ basis from $60227.0 in Q4 2025, and down 70.14% year-over-year from $189282.0 in Q1 2025.
Powered by 
Analysis
Bioregenx (BRGX) Current Deferred Revenue (2022 - 2026) Analysis & Trends
Bioregenx has reported Current Deferred Revenue for 5 years, with the latest figure at $56528.0 in Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 70.14% year-over-year to $56528.0 in Q1 2026; TTM through Mar 2026 was $56528.0, a 70.14% decrease from a year earlier, with the FY2025 full-year figure at $60227.0, down 69.43% from the prior year.
- Current Deferred Revenue was $56528.0 for Q1 2026 at Bioregenx, down from $60227.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $629000.0 in Q4 2022, with the low at $56528.0 in Q1 2026.
- Average Current Deferred Revenue over 5 years is $219424.3, with a median of $189282.0 recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue tumbled 36.12% in 2025, then sank 70.14% in 2026.
- Over 5 years, Current Deferred Revenue stood at $629000.0 in 2022, then tumbled by 43.69% to $354203.0 in 2023, then slumped by 44.37% to $197027.0 in 2024, then sank by 69.43% to $60227.0 in 2025, then dropped by 6.14% to $56528.0 in 2026.
- The last three Current Deferred Revenue figures came in at $56528.0 (Q1 2026), $60227.0 (Q4 2025), and $95775.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 56,528.00 |
| Dec 31, 2025 | 60,227.00 |
| Sep 30, 2025 | 95,775.00 |
| Jun 30, 2025 | 125,174.00 |
| Mar 31, 2025 | 189,282.00 |
| Dec 31, 2024 | 197,027.00 |
| Sep 30, 2024 | 165,574.00 |
| Jun 30, 2024 | 195,938.00 |
| Mar 31, 2024 | 344,939.00 |
| Dec 31, 2023 | 354,203.00 |
| Dec 31, 2022 | 629,000.00 |
API Access
Bioregenx Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BRGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BRGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BRGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();